AT-19 SINGLE INSTITUTION RETROSPECTIVE COMPARISON OF GLIOBLASTOMA (GBM) PATIENTS (PTS) INITIATED ON BEVACIZUMAB (BEV) BEFORE VERSUS AFTER RECURRENCE IN CLINICAL PRACTICE

BACKGROUND: BEV monotherapy received accelerated approval in May 2009 for the treatment of progressive GBM pts. We performed a retrospective chart review of GBM pts initiated on BEV at Duke before first disease progression (BEV-early) versus after the time of recurrence (BEV-late) to understand outc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Desjardins, Annick, Herndon, James, McSherry, Frances, Ravelo, Arliene, Lipp, Eric, Healy, Patrick, Boulton, Susan, Peters, Katherine, Vlahovic, Gordana, Sampson, John, Friedman, Allan, Friedman, Henry
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4217796/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou237.19
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados